Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea · Delayed Price · Currency is KRW 83,000
+2,500 (3.11%)
May 12, 2026, 9:59 AM KST
Mezzion Pharma Market Cap
Mezzion Pharma has a market cap or net worth of 2.45 trillion as of May 11, 2026. Its market cap has increased by 128.72% in one year.
Market Cap
2.45T
Enterprise Value
2.43T
Revenue
7.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
83,000.00
Market Cap Chart
Since January 20, 2012, Mezzion Pharma's market cap has increased from 240.02B to 2.45T, an increase of 919.31%. That is a compound annual growth rate of 17.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 2.45T | -10.57% |
| Dec 30, 2025 | 2.74T | 195.96% |
| Dec 30, 2024 | 924.37B | -19.89% |
| Dec 28, 2023 | 1.15T | 231.92% |
| Dec 29, 2022 | 347.65B | -82.01% |
| Dec 30, 2021 | 1.93T | 23.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 68.14T |
| Celltrion | 41.58T |
| ALTEOGEN | 18.22T |
| Samsung Epis Holdings | 13.19T |
| ST Pharm | 3.25T |
| Hugel | 3.15T |
| D&D Pharmatech | 3.10T |
| Hanmi Science | 2.51T |